cobas Influenza A/B & RSV Nucleic Acid Test for Use on the cobas Liat System
K-Number: K153544 · 2016-07-25
Device Summary
Frequently Asked Questions
What is the cobas Influenza A/B & RSV Nucleic Acid Test for Use on the cobas Liat System?
cobas Influenza A/B & RSV Nucleic Acid Test for Use on the cobas Liat System is a medical device that received FDA 510(k) clearance on 2016-07-25. It is manufactured by Iquum, Inc.. The 510(k) number is K153544.
When was cobas Influenza A/B & RSV Nucleic Acid Test for Use on the cobas Liat System approved by the FDA?
cobas Influenza A/B & RSV Nucleic Acid Test for Use on the cobas Liat System received FDA 510(k) clearance on 2016-07-25, under approval number K153544.
What company makes cobas Influenza A/B & RSV Nucleic Acid Test for Use on the cobas Liat System?
cobas Influenza A/B & RSV Nucleic Acid Test for Use on the cobas Liat System is manufactured by Iquum, Inc..
What is the FDA product code for cobas Influenza A/B & RSV Nucleic Acid Test for Use on the cobas Liat System?
The FDA product code for cobas Influenza A/B & RSV Nucleic Acid Test for Use on the cobas Liat System is OCC.
Related Clinical Trials
Related Devices (Code: OCC)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.